A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18- 40 Years of Age
Clinical trial NCT00645346 · COMPLETED
Trial details
- NCT number
- NCT00645346
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2009-05-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.